首页 | 本学科首页   官方微博 | 高级检索  
     

综合干预在高血压病患者中的应用探讨
引用本文:生金丽. 综合干预在高血压病患者中的应用探讨[J]. 中国药物经济学, 2012, 0(3): 144-146
作者姓名:生金丽
作者单位:山东省东营市东营区人民医院,山东东营,257000
摘    要:目的探讨综合干预对高血压病的治疗作用及对其后的影响。方法对高血压病患者进行定点、定点监测,同时进行家庭随访,综合干预,并与对照组进行前瞻性对照研究。结果入组前患者收缩压(157.5±9.0)mmHg(1mmHg=0.133kPa)、舒张压(95.0±16.5)mmHg,3年后收缩压(130.6±11.0)mmHg、舒张压(80.0±12.0)mmHg,与对照组比较,P<0.001;两组之间的降压幅度比较,P<0.05。患者的生活习惯有了改善,生活质量明显提高,并发症、致残率和病死率是对照组的20%。两组90项症状比较,干预组总分下降具有显著意义。结论高血压病严重威胁健康,社区家庭干预和健康宣教疗效肯定;公众教育、专业人员教育和高血压病患者教育还任重而道远。

关 键 词:高血压病人  综合干预

Comprehensive intervention in hypertensive patients is discussed in the application
Sheng Jin Li. Comprehensive intervention in hypertensive patients is discussed in the application[J]. China Journal of Pharmaceutical Economics, 2012, 0(3): 144-146
Authors:Sheng Jin Li
Affiliation:Sheng Jin Li
Abstract:Objective To explore the effect of comprehensive intervention on hypertension disease and treatment of subsequent effects.Method For patients with hypertension were fixed,monitoring,and home follow-up,intervention,and the control group performed a prospective controlled study.Results In the group of former patients with systolic blood pressure(157.5±9) mmHg(1mmHg=0.133kPa),diastolic blood pressure(95±16.5) mmHg,3 years after the systolic blood pressure(130.6±11) mmHg,diastolic blood pressure(80±12)mmHg,compared with the control group,P<0.001;between the two groups of antihypertensive amplitude comparison,P<0.05.Patients living habits have been improved,life quality rises apparently,complications,disability rate and fatality rate is20% in the control group.Two groups of90comparison of symptoms,the intervention group was significantly declined in significance score.Conclusion Hypertension serious threats to the health,community and family intervention and health education effect of certain;public education,professional education and hypertensive patients education still has a long way to go.
Keywords:Hypertension patients  Comprehensive intervention
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号